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Abstract
Cadmium is a metalloestrogen known to activate the estrogen receptor and promote breast cancer cell growth.
Previous studies have implicated cadmium in the development of more malignant tumors; however the molecular
mechanisms behind this cadmium-induced malignancy remain elusive. Using clonal cell lines derived from exposing
breast cancer cells to cadmium for over 6 months (MCF-7-Cd4, -Cd6, -Cd7, -Cd8 and -Cd12), this study aims to
identify gene expression signatures associated with chronic cadmium exposure. Our results demonstrate that
prolonged cadmium exposure does not merely result in the deregulation of genes but actually leads to a distinctive
expression profile. The genes deregulated in cadmium-exposed cells are involved in multiple biological processes
(i.e. cell growth, apoptosis, etc.) and molecular functions (i.e. cadmium/metal ion binding, transcription factor activity,
etc.). Hierarchical clustering demonstrates that the five clonal cadmium cell lines share a common gene expression
signature of breast cancer associated genes, clearly differentiating control cells from cadmium exposed cells. The
results presented in this study offer insights into the cellular and molecular impacts of cadmium on breast cancer and
emphasize the importance of studying chronic cadmium exposure as one possible mechanism of promoting breast
cancer progression.
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Introduction
The International Agency for Research on Cancer and the
National Toxicology Program of the United States of America
have classified cadmium as a category I human carcinogen
[1,2] because increasing evidence shows both occupational
and non-occupational exposure to cadmium are associated
with cancers of the lung, prostate, pancreas, kidney, liver,
stomach, and urinary bladder [3-9]. Cadmium exposure has
also been correlated with an increase in the incidence of breast
cancer [10-12]. Recent studies have identified significantly
higher levels of cadmium in tumor tissues as well as in other
biological samples from tumor patients [8,13,14]. Specifically,
Strumylaite et al. found that patients with malignant breast
cancer had accumulated significantly higher levels of cadmium
when compared to patients with benign tumors [13] offering
further support for a possible relationship between cadmium
and breast cancer progression.
Several studies have shown that cadmium has the ability to
mimic the biological functions of estrogen in breast cancer cells
by activating the estrogen receptor [11,15-20]. Previous work
from our lab and others has suggested that cadmium can
promote MCF-7 breast cancer cell growth via ERα [11,16,19].
Animal studies have revealed that, similar to estrogen,
cadmium promotes neoplastic growth, increases uterine
weight, induces changes in the uterine lining, and increases the
density of mammary glands in rats and mice [17,21-23].
Collectively, these studies demonstrate that cadmium functions
as a hormone-disruptor and metalloestrogen and is an
important contributor to the development of breast cancer.
Several studies have also shown that cadmium exposure is
associated with the development of more malignant tumors
[6,24,25]. Furthermore, results from our recent study have
suggested that cells chronically exposed to cadmium acquire a
more metastatic phenotype that includes an increased ability to
migrate and invade [20]. We demonstrated that prolong
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exposure to cadmium induces cellular changes brought about
by changes in the expression of genes such as SDF-1;
however a comprehensive molecular understanding of how
chronic exposure to cadmium mediates these changes in
phenotype remains unclear.
In this study, microarray analysis was used to investigate the
effect of prolonged cadmium exposure on gene expression by
comparing the global gene expression of MCF-7 breast cancer
cells chronically exposed to cadmium with that of control
MCF-7 cells. Genes that were differentially expressed in
cadmium-adapted cells were further analyzed.
Materials and Methods
Cell Culture
MCF-7 cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA). MCF-7 cells were
maintained in complete media: Dulbecco’s Modified Eagle
Medium (DMEM) plus 10% fetal bovine serum and 1%
penicillin and streptomycin (Hyclone, Logan, UT). Cadmium-
adapted cell lines (MCF-7-Cd4, -Cd6, -Cd7, -Cd8 and -Cd12)
were derived as previously described [20], and maintained in
complete media but supplemented with 10-7 M CdCl2.
Affymetrix Microarray
Equal numbers of MCF-7 and MCF-7-Cd4, -Cd6, -Cd7, -Cd8,
and -Cd12 cells were plated in 10 cm plates and semi-
synchronized by serum starvation. Twenty-four hours later,
media containing hormone (DMEM+ 10% FBS) were added
back to cells. Cells were harvested 10 hours later for total RNA
isolation using Direct-zol™ RNA MiniPrep (Zymo Research
Corporaton, Irvine, CA) according to manufacturer’s protocol.
In short, cells were lysed with TRI-Reagent and mixed with
equal volume of 100% ethanol. Mixture was transferred to a
Direct-zol column and following several washes, total RNA was
eluted using nuclease-free water. Microarray experiments were
performed by the QB3-Functional Genomics Lab at UC
Berkeley (Berkeley, CA) using GeneChip® Human Gene 1.0 ST
arrays (Affymetrix, Santa Clara, CA). Expression signals were
extracted and normalized by means of the Expression Console
software (Affymetrix) applying the Robust Multichip Average
(RMA) normalization method [26]. The complete microarray
expression data are available at the NCBI´s Gene Expression
Omnibus (GEO) (accession GSE52404).
Quantitative Reverse Transcriptase-Polymerase Chain
Reaction (qRT-PCR)
Total RNA was isolated from cells using Direct-zol RNA
MiniPrep kit according to manufacturer’s protocol (Zymo
Research Corporation, Irvine, CA). Three micrograms (μg) of
total RNA were used for the reverse transcription reaction with
oligo-dT18 primers and Moloney Murine Leukemia Reverse
Transcriptase (M-MLV RT, Promega, Madison,WI). Gene
expression was monitored using SYBR-green based qRT-PCR
(Viia-7; Applied Biosystems, Life Technologies, Grand Island,
NY). All primers were synthesized by Integrated DNA
Technologies, Inc. (IDT; San Diego, CA). The primer
sequences are listed in Table 1.
Hierarchical clustering
Hierarchical clustering of the samples was performed to
determine if cadmium exposed samples could be separated
from the control samples. Clustering was performed with Java-
based desktop application MultiExperiment Viewer (MeV) [27]
by using the average linkage rule and Pearson correlation as
the similarity metric.
Identifying differentially expressed (DE) genes
To understand the effects of chronic cadmium exposure on
gene expression in breast cancer, two control MCF-7 parental
cell lines and five different clonal cadmium-adapted cell lines
(MCF-7-Cd4, -Cd6, -Cd7, -Cd8, and -Cd12)— previously
derived from cells chronically exposed to cadmium— were
used for microarray analysis. Expression signals were
extracted and normalized by means of the Expression Console
software (Affymetrix) applying the Robust Multichip Average
(RMA) normalization method [26]. The data were background
corrected, normalized (Quantile) and summarized
(MedianPolish). Differentially expressed genes were identified
with Significance Analysis of Microarrays – SAM [27,28]. SAM
relies on a modified t-test to determine the significance of the
expression level of each gene. SAM then uses permutations to
estimate the false discovery rate (FDR) [29] i.e. the fraction of
false positive genes. Cut-off for FDR was set to 0.05 in order to
identify genes with significantly aberrant expression levels to
be further analyzed.
Functional enrichment of the DE genes
A total of 795 DE genes were used as input for further
analysis. A singular enrichment analysis (SEA) was applied to
identify the annotation terms that are overrepresented in our
gene list. Following SEA, two additional enrichment analysis
tools were used; the first was Database for Annotation,
Visualization and Integrated Discovery (DAVID; http://
david.abcc.ncifcrf.gov/) [30], which relies on a modified Fisher's
exact test (EASE score), and the second is Onto-Express
Table 1. Primer Sequences.
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[31,32] (http://vortex.cs.wayne.edu/projects.htm) which
implements a hypergeometric statistical method. Both of the
tools rely on Gene Ontology (GO) as a primary annotation
source, but also integrate other annotation sources.
Furthermore, genes that are known to be associated with
breast cancer were identified using Genes-to-Systems Breast
Cancer Database - G2SBC (http://www.itb.cnr.it/breastcancer/)
[33], which gathers information about genes that have been
previously reported in literature to be associated with breast
cancer. Gene Expression Atlas - GXA (http://www.ebi.ac.uk/
gxa) from EMBL-EBI database [34] was also used for further
investigation of DE genes by searching for previously
described gene expression patterns associated with different




We performed hierarchical clustering of the samples to see if
there is a separation between control MCF-7 cells and those
treated with cadmium for over 6 months. Figure 1 shows a
dendogram with two major branches, confirming the
discrimination between control and cadmium-treated samples.
This suggests that genes differentially expressed in breast
cancer cells chronically exposed to cadmium can be identified
using this set of microarray data.
Identifying differentially expressed genes
SAM analysis was used to identify differentially expressed
(DE) genes, and this revealed 944 DE genes at FDR<0.05.
Among these are 371 over-expressed and 573 are under-
Figure 1.  Dendrogram of hierarchical clustering
showing a clear distinction between control MCF-7 and
cells chronically exposed to cadmium.  
doi: 10.1371/journal.pone.0084646.g001
expressed genes. The gene list was then filtered by removing
duplicate gene symbols resulting in 795 DE genes (Table S1),
which were used for further analysis. Table 2 shows a list of the
top 30 over-expressed genes, along with the associated q-
value (measure of significance in terms of false discovery rate),
fold change log (FClog) and gene description. A corresponding
list of 30 under-expressed genes can be found in Table 3. For
a complete list of DE genes, see supplemental information
(Table S1).
Amongst the over-expressed genes in Table 2, some genes
are expected to show differential gene expression after
cadmium exposure, including those associated with endocrine
disruption and heavy metal toxicity. Prior to identifying these
genes, an initial search of all listed genes was done using
Gene Expression Atlas (GXA) to find genes with expression
patterns associated with estrogenic effects and metal/cadmium
toxicity. In the case of endocrine disruption effects, the genes
that were up-regulated and associated with this function
include ULBP2, MT1F, DKK1, PDLIM1, PTP4A3, ANXA2P2,
Table 2. 30 over-expressed genes with lowest q-value.
Gene symbol   FClog   q-value Gene description
ANXA3 2.15 0.00E+00 annexin A3
ULBP2 1.65 1.67E-02 UL16 binding protein 2
MT1F 1.46 1.67E-02 metallothionein 1F
SCARNA9 1.23 1.67E-02 small Cajal body-specific RNA 9
MT1L 1.21 1.42E-02 metallothionein 1L
DKK1 1.18 1.42E-02 dickkopf homolog 1
PDLIM1 0.98 1.51E-02 PDZ and LIM domain 1
PTP4A3 0.98 1.67E-02
protein tyrosine phosphatase type IVA,
member 3
ANXA2P2 0.97 1.42E-02 annexin A2 pseudogene 2
MT1X 0.97 5.87E-03 metallothionein 1X
PRSS8 0.90 6.81E-03 protease, serine, 8
CERCAM 0.85 1.42E-02 cerebral endothelial cell adhesion molecule
CRABP1 0.83 1.67E-02 cellular retinoic acid binding protein 1
CBFA2T3 0.79 1.51E-02
core-binding factor, runt domain, alpha subunit
2; transloc to 3
DECR1 0.76 1.64E-02 2,4-dienoyl CoA reductase 1
FSTL3 0.75 1.19E-02 follistatin-like 3
UCP2 0.73 1.64E-02 uncoupling protein 2
FKBP9 0.73 1.62E-02 FK506 binding protein 9
ZNF286B 0.71 1.67E-02 zinc finger protein 286B
MT2A 0.66 0.00E+00 metallothionein 2A
TRADD 0.62 1.19E-02 TNFRSF1A-associated via death domain
CRYL1 0.62 1.42E-02 crystallin, lambda 1
ZNHIT2 0.59 1.67E-02 zinc finger, HIT-type containing 2
ATP2A3 0.54 1.67E-02 ATPase, Ca++ transporting, ubiquitous
SRD5A1 0.53 1.64E-02 steroid-5-alpha-reductase, alpha polypeptide 1
RAB32 0.52 1.67E-02 RAB32, member RAS oncogene family
TMEM8A 0.49 1.58E-02 transmembrane protein 8A
ZP1 0.49 1.19E-02 zona pellucida glycoprotein 1 (sperm receptor)
SLC15A4 0.45 1.19E-02 solute carrier family 15, member 4
CCNE1 0.45 1.51E-02 cyclin E1
Underlined genes are known to be associated with breast cancer.
doi: 10.1371/journal.pone.0084646.t002
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MT1X, PRSS8, CERCAM, CRABP1, CBFA2T3, DECR1,
FSTL3, UCP2, FKBP9, ZNF286B, MT2A, TRADD, CRYL1,
ZNHIT2, ATP2A3, SRD5A1, RAB32, ZP1, SLC15A4, CCNE1
and ANXA3 (Table 2), while genes SH3GL3, TK1, CYP24A1,
PGK1, TAF9B, SSX2, TBX4, SPDYE1, RHEBL1 and ABCA6
were down-regulated (Table 3). We also identified DE genes
associated with heavy metal toxicity and these genes include
MTJF, MT1L, MT1X, and MT2A which are up-regulated (Table
2), while CYP24A1 and TK1 genes associated with calcium
homeostasis and zinc binding, respectively are down-regulated
(Table 3).
Apart from this, several of the DE genes were already known
to be associated with breast cancer, not unexpected since
cadmium has been shown to be involved in the development
Table 3. 30 under-expressed genes with lowest q-value.
Gene symbol FClog   q-value Gene description
SH3GL3 -0.52 5.16E-03 SH3-domain GRB2-like 3
NPSR1 -0.62 0.00E+00 neuropeptide S receptor 1
TK1 -0.62 6.47E-03 thymidine kinase 1, soluble
RHEBL1 -0.65 0.00E+00 Ras homolog enriched in brain like 1
GPR128 -0.68 5.54E-03 G protein-coupled receptor 128
REXO1L2P -0.73 5.62E-03
REX1, RNA exonuclease 1 homolog (S.
cerevisiae)-like 2
LPAR6 -0.75 5.83E-03 lysophosphatidic acid receptor 6
ABCA6 -0.77 0.00E+00 ATP-binding cassette, sub-family A
SPDYE1 -0.82 0.00E+00 speedy homolog E1 (Xenopus laevis)
PGK1 -0.83 0.00E+00 phosphoglycerate kinase 1
TAF9B -0.87 0.00E+00
RNA polymerase II, TATA box binding
protein-associated factor
SPDYE8P -0.91 0.00E+00 speedy homolog E8 (Xenopus laevis)
SNORD115-20 -0.92 5.79E-03 small nucleolar RNA, C/D box 115-11
SSX2 -0.95 0.00E+00 synovial sarcoma, X breakpoint 2
OR2AT4 -1.05 5.87E-03
olfactory receptor, family 2, subfamily AT,
member 4
SSX4 -1.08 0.00E+00 synovial sarcoma, X breakpoint 4
OCM2 -1.13 6.06E-03 oncomodulin 2
TBX4 -1.17 0.00E+00 T-box 4
OR7E87P -1.18 0.00E+00
olfactory receptor, family 7, subfamily E,
member 87
LOC652493 -1.32 5.87E-03
similar to pre-B lymphocyte gene 1
gene:ENSG00000241755
OCM -1.33 0.00E+00 oncomodulin
CYP24A1 -1.38 0.00E+00
cytochrome P450, family 24, subfamily A,
polypeptide 1
SNORD59B -1.55 5.87E-03 small nucleolar RNA, C/D box 59B
IGLJ3 -1.63 0.00E+00 mRNA for scFv collagenase IV antibody
IGHA1 -1.64 0.00E+00 cDNA FLJ46621 fis, clone TLUNG2001445
SUMO1P1 -1.88 0.00E+00 SUMO1 pseudogene 1
DUB3 -1.88 0.00E+00 ubiquitin specific peptidase 17-like 2
DUB4 -2.00 0.00E+00
ubiquitin specific peptidase 17-like 6
(pseudogene)
USP17 -2.07 0.00E+00 ubiquitin specific peptidase 17
IGHD -2.11 0.00E+00 immunoglobulin heavy constant delta
Underlined genes are known to be associated with breast cancer.
doi: 10.1371/journal.pone.0084646.t003
and progression of breast cancer [17,19,20,35,36]. Among the
genes in Table 2, eight are known to be associated with breast
cancer including: ANXA3 (Annexin A3), an inhibitor of
phospholipase A2; DKK1 (Dickkopf), a precursor protein that
inhibits the Wnt signaling pathway; PDLIM1 (DZ and LIM
domain protein 1), a protein that has been shown to interact
with ERα; CRABP1 (cellular retinoic acid-binding protein), a
protein that may play a role in retinoic acid-mediated
differentiation and proliferation; SRD5A1 (5-a reductase type
1), an enzyme involved in the metabolism of progesterone;
MT2A (metallothionein 2A), metal response protein; UCP2
(uncoupling protein 2), an inner mitochondrial membrane anion
carrier that negatively regulates reactive oxygen species
production; and CCNE1 (cyclin E1), a G1/S cyclin that
regulates cell cycle progression. Two additional genes in Table
3— TKI (Thymidine kinase 1) and PGK1 (Phosphoglycerate
kinase 1)— are also known to be associated with breast
cancer. Other than the genes highlighted in Tables 2 and 3,
analysis of the complete list of DE genes identified an
additional 87 genes with known breast cancer association.
These are all summarized in the heat map shown in Figure 2.
Specifically, the heat map is used to highlight the expression
pattern of breast cancer associated genes in the cadmium
samples in comparison to the control samples with the
dendrogram of the genes shown on the left-hand side, and the
dendrogram on top depicting the different samples.
Hierarchical clustering method based on Pearson dissimilarity
metric was used to create the dendrograms. The heat map also
indicates that the set of breast cancer associated genes follows
similar expression pattern as the whole set of DE genes,
clearly separating control cells from cadmium-exposed cells.
This subset of genes is differentially expressed in all five clonal
cadmium cell lines suggesting that a common gene expression
signature does exist in cells chronically exposed to cadmium.
Functional enrichment analysis of the DE genes
We performed gene annotation enrichment analysis of DE
genes, focusing on Gene Ontology (GO), which is the de facto
method for functional annotation and also used as a primary
annotation source in the majority of enrichment tools. Initially,
we applied DAVID to identify significant annotation terms GO
molecular function (GO MF) and GO biological process (GO
BP) terms— with the purpose of finding important biological
functions and processes that characterize the impact of the DE
genes identified in our study. Out of 795 DE genes, there were
783 hits found in DAVID. We applied a cut-off p<0.05 to derive
significantly over-represented GO MF and GO BP terms
(Figure 3A and B). Among the GO BP terms identified by
DAVID, the most significantly enriched term is “regulation of
fibroblast proliferation” (p-value = 2.29E-04), with 8 genes
assigned to it. One of the up-regulated genes in this set is
IFI30, interferon gamma-inducible protein 30, which is linked to
breast cancer [37,38]. Other GO BP terms of interest include
“cell division” (19 genes), “nuclear division” (18 genes), and “G-
protein coupled receptor protein signaling pathway” (58 genes).
Many of the genes assigned with these terms are known to
contribute to cancer cell growth and development. Among the
most significantly enriched GO MF terms are the “cadmium ion
Cadmium Alters Gene Expression in Breast Cancer
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Figure 2.  Heat map showing expression of 97 breast cancer associated genes that are differentially expressed between
control and cadmium-adapted cells.  Each row represents a gene and each column represents a sample.
doi: 10.1371/journal.pone.0084646.g002
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binding” (p = 1.6E-05) and “copper ion binding” (p = 2.5E-04)
(Figure 3A).
A more in-depth analysis of the DE genes was done using
Onto-Express, which also provides graphical tree view for GO
terms, with the ability to browse functional profiles of the GO
tree at different abstraction levels. Results in Figures 4 and 5
represent the identified GO MF and GO BP terms amongst the
DE genes, along with the number of under- and over-
expressed genes for each identified term using Onto-Express.
In the final GO annotation analysis, we combined the results
from DAVID with Onto-Express to derive the overrepresented
GO categories. Among the GO MFs of interest are the
“cadmium ion binding”, “metal ion binding, “zinc ion binding”,
and “calcium ion binding” genes. The GO BP categories of
interest include “cell division”, “cell proliferation”, and “cell
cycle”. We further evaluated these GO categories. Table 4
shows the four GO MFs associated with the metal/cadmium
response, and the list of genes in each of the categories; and
Table 5 shows the three GO BPs linked to cell growth and the
respective genes in each category.
Confirmation of DE genes using quantitative RT-PCR
Differential expression of some of the genes identified in
Tables 4 and 5 was further verified using quantitative RT-PCR.
Total RNA from both parental MCF-7 and cadmium-exposed
cell lines was isolated for gene expression analysis using gene
specific primers and SYBR-green based quantitative-PCR.
Relative fold changes were calculated based on expression
levels in parental MCF-7 cells and subsequently normalized to
the housekeeping gene, GAPDH (glyceraldehyde
dehydrogenase). Consistent with Table 4, results in Figure 6A
confirm that the expressions of ANXA3, MT1X and MT2A were
elevated in cells chronically exposed to cadmium, with fold
changes ranging from 2- to 10-fold (p < 0.001). Figure 6B
shows the fold changes of cell cycle related genes— CCNE2,
CCNB1, BUB1 and CENPF (p < 0.001). Among these genes,
only CCNE2 is up-regulated in cells chronically exposed to
cadmium, whereas CCNB1, BUB1 and CENPF are all down-
regulated. Specific fold changes are summarized in Table 6 for
each of the cadmium cell lines.
Discussion
Multiple studies have suggested that cadmium functions as a
metalloestrogen, mimicking the actions of estrogen to promote
breast cancer cell proliferation via the activation of the estrogen
receptor (ERα) [16,18,19]. Additionally, studies have also
demonstrated that exposure to cadmium is associated with the
development of more malignant tumors [6,24,25]. While acute
cadmium exposure and correlation studies exist at the tumor
tissue level, there are very few cellular models aimed at
studying chronic cadmium exposure and breast cancer. We
have previously developed clonal cadmium cell lines (MCF-7-
Cd4, -Cd6, -Cd7, -Cd8 and -Cd12), derived from cells exposed
to cadmium for over 6 months, which serve as a cell culture
model to study chronic cadmium exposure [20]. While we have
previously demonstrated that prolonged exposure to cadmium
induces cellular changes [20]— most likely due to changes in
gene expression— the impacts of chronic cadmium exposure
on global gene expression remains unclear. To establish
expression profiles of cells chronically exposed to cadmium, we
used microarray analysis to investigate the effects of prolonged
cadmium exposure on gene expression in comparison with
control MCF-7 breast cancer cells. High throughput microarray
technology is commonly used to identify differentially
expressed genes, and previous research using microarray
platforms has demonstrated its potential in case-controlled
gene expression comparisons [39,40]. Hierarchical clustering
analysis of the microarray data (Figure 1) confirmed that
distinct expression patterns exist between parental MCF-7 and
cadmium-adapted cells, thus warranting further analysis.
Results in Tables 2 and 3 provide an abbreviated lists of
over- and under-expressed genes in cells chronically exposed
to cadmium. Genes with known associations to breast cancer
were identified using Genes-to-Systems Breast Cancer
Database— G2SBC (http://www.itb.cnr.it/breastcancer/), which
contains information about genes that have been previously
reported in the literature to be associated with breast cancer.
Furthermore, Gene Expression Atlas (GXA) from EMBL-EBI
database [34] was used to further investigate DE genes by
searching for previously described gene expression patterns
associated with breast cancer and different biological/
experimental conditions, such as estrogen treatment. Genes
associated with breast cancer were then organized and
represented in a heat map (Figure 2), and similar to the
hierarchical clustering in Figure 1, there is a clear expression
pattern among the breast cancer associated genes in
cadmium-exposed samples. Interestingly, among the over-
expressed genes (Table 2), MT2A (metallothionein 2A) and
CCNE1 (cyclin E1) are associated not only with breast cancer,
but also with cadmium induction [19,41-43] suggesting that the
microarray analysis is identifying genes relevant to both
cadmium exposure and breast cancer.
More in-depth analysis was accomplished using functional
annotations; and an initial overview of the functional annotation
of DE genes in terms of molecular functions and biological
processes was obtained by using DAVID (Figure 3). Since
Gene Ontology (GO) is the de facto method for functional
annotation, tools that primarily use GO as their annotation
resource were initially used in gene enrichment analysis. As
there is no standard to determine which functional enrichment
analysis tools should be used, it is advantageous to run more
than one tool in order to compensate for any weaknesses.
DAVID was used for an initial analysis to identify the most
significantly enriched terms, but because of high stringency,
there is a risk for neglecting some weakly enriched terms,
which may bias the biological conclusion. Therefore, we also
performed a functional annotation analysis using Onto-Express
(Figure 4 and 5) to give us a broader picture of cadmium’s
effect. The results from DAVID complemented the results from
Onto-Express which allow customized analysis with the
possibility of collapsing or expanding GO term nodes (and
calculate corresponding p-values) to give us more in-depth
analysis of the DE genes.
From this analysis, we identified GO categories of interest,
including genes that are associated with cadmium and other
Cadmium Alters Gene Expression in Breast Cancer
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e84646
Figure 3.  Over-represented Gene Ontology (GO) annotation among differentially expressed genes.  GO categories identified
using Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/). A) Biological Process
and B) Molecular Function.
doi: 10.1371/journal.pone.0084646.g003
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divalent metal ions (i.e. zinc and calcium). There were four GO
terms identified in this category: cadmium-, zinc-, calcium- and
iron-ion binding genes (Table 4). As expected, many of
metallothionein genes that are known to be induced by zinc
Figure 4.  Gene Ontology (GO) categories denoting Molecular Function (MF) information for differentially expressed
genes.  Information is derived using Onto-Express (http://vortex.cs.wayne.edu/projects.htm). Diagram shows the number of under-
and over-expressed genes for each GO MF. The MF marked with stars denotes a statistically significant group (p<0.05). Only the
groups with a gene number ≥ 5 are shown.
doi: 10.1371/journal.pone.0084646.g004
Cadmium Alters Gene Expression in Breast Cancer
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(MTA2, MT1X, etc.) and play important roles in the
detoxification and transport of metal ions [44-46], were also
induced by chronic cadmium exposure. Consistent with this
observation, a previous study carried out on both immortalized
human breast epithelial cells (HB2) and ER-negative breast
cancer cells (MDA-MB-231) also reported the induction of
multiple metallothionien genes (MT1F, MT1L, etc.) in response
to cadmium exposure [47]. Furthermore, cadmium has been
shown to induce the expression of metallothionein genes in
other cancer cell types including prostate, testes, liver and
lymphocytes [48-50]. Other metal binding genes that were
elevated in response to chronic cadmium exposure included
Figure 5.  Gene Ontology (GO) categories denoting Biological Process (BP) information for differentially expressed
genes.  Information is derived using Onto-Express (http://vortex.cs.wayne.edu/projects.htm). Diagram shows the number of under-
and over-expressed genes for GO BP. The BP marked with stars denotes a statistically significant group (p<0.05). Only the groups
with a gene number ≥ 5 are shown.
doi: 10.1371/journal.pone.0084646.g005
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MMP17 (matrix metalloproteinase-17), ANXA3 (annexin A3)
and STAC2 (Src homology 3 and cysteine-rich domain-
containing protein 2). The ability of cadmium to stimulate the
expression of metal-binding proteins is likely associated with its
ability to mimic divalent cations like calcium [51,52] and/or
replace cations like zinc [53-57]. Specifically, cadmium has
been shown to replace the zinc ions within the DNA binding
domain of the estrogen receptor [58,59].
The second GO category that underwent further analysis
involved cell growth, which included three GO terms: cell cycle,
cell division and cell proliferation (Table 5). Previous studies
have implicated cadmium in mediating breast cancer cell
proliferation [19,60,61], and in line with these previous reports,
our microarray analysis identified over 35 growth-related genes
deregulated in cells chronically exposed to cadmium. Among
these are CCNE1 (cyclin E1), CCNE2 (cyclin E2), CCNB1
(cyclin B1), and CCNF (cyclin F), all of which are direct
regulators of the cell cycle. Cyclin E1 and 2— known to be
involved in the regulation of the G1/S transition— are increased
in cells chronically exposed to cadmium. Induction of cyclin E1
was also identified in our previous acute cadmium study on
breast cancer cells [19]. On the other hand, cyclin B1 and F
important for regulating the G2/M transition [62-68] are both
down-regulated in the cadmium-adapted cells. The
deregulation of any of these cyclins has been shown to be
sufficient to promote cancer cell proliferation [41,67-73].
Furthermore, in addition to the cyclins, two other proteins that
regulate the cell cycle— wee1 and BUB1— were also down-
regulated. Wee1 is a serine/threonine protein kinase that
catalyzes the inhibitory tyrosine phosphorylation of cdk1/cyclin
B complex and coordinates the transition between DNA
replication and mitosis, whereas BUB1 is a mitotic checkpoint
serine/threonine-protein kinase.
Expression of a select number of genes from both GO
categories (cadmium/metal binding and cell growth) were
further evaluated using quantitative RT-PCR, and results
confirmed that the specific genes were in fact deregulated in
cells chronically exposed to cadmium in comparison to parental
MCF-7 cells (Figure 6). While the qRT-PCR data were
consistent with microarray data regarding the direction of
change (up- or down-regulated), the relative fold changes
found with qRT-PCR were much greater than those calculated
in the microarray analysis. This is likely due to the higher
noise:signal ratio associated with microarray analyses [74].
While this study was focused on ER-positive breast cancer
cells, chronic cadmium exposure is also relevant to other
cancer cell types. As noted earlier, some of the genes identified
in this study were also deregulated in other cancer cells when
exposed to cadmium [47-50]. A more recent study by Garrett
and colleagues on acute (1 day) and chronic (13 days)
cadmium exposure in kidney tubule cells also used microarray
analysis to examine the gene expression profiles of cells
Table 4. GO Molecular Function: Metal ions.
GO ID Description
No of
genes   Gene members
GO:0046870 cadmium ion binding 5 MT1X, MT1M, MT1H, MT1G, MT1F
GO:0008270 zinc ion binding 71
ZNF552, CYHR1, ZNF90, RACGAP1, C20orf12, RNF183, PDLIM1, RNF4, MT2A, MT1X, MT1M, MT1H, MT1G, MT1F,
RING1, RNF135, CPN1, RNF8, RASA3, RABGGTA, MMP17, ZNF467, ZNF831, ADAM5P, ADAM15, FBLIM1,
PRKCZ, ZNF256, RFFL, RASGRP1, AGAP7, CBFA2T3, LASP1, SNAI3, LMCD1, AGAP4, FAM90A7, CA4, ZNF282,
ZNHIT2, ZFP36L2, FBXO43, CA14, ZNF404, MEX3D, ZNF286A, JUB, RNF39, SOLH, SYTL5, TRIM17, ZDHHC9,
ZIM3, DPF3, EGR1, P2RX4, RUFY1, ZMIZ1, CIT, STAC2, ZNF709, TRIM49, CPO, ZNF296, RNF208, ATXN7, ZXDA,
RREB1, ZFAND2A, ZNF554, ZNF187
GO:0005509 calcium ion binding 31
AVIL, MYL12A, CRP, SYT7, VSNL1, MMP17, LRP2, CADPS, RASGRP1, SLC25A24, PLS3, PLA2G2A, CIB3, F8,
FKBP9, FAHD1, ATP2A3, EMR1, ASGR1, OCM, SGSH, ANXA3, ANXA2P2, ANXA2, AMY2A, EMR3, S100A10,
CD209, FSTL5, DAG1, CADPS2
GO:0005506 iron ion binding 2 OGFOD1,NDUFS7
Genes that are highlighted in bold are over-expressed, and the rest of the genes are under expressed.
doi: 10.1371/journal.pone.0084646.t004
Table 5. GO Biological Process: Cell Growth.
GO ID Description No genes   Gene members
GO:0051301 cell division 15 CCNE2, RNF8, WEE1, CKS1B, SETD8, CENPF, CCNF, CCNE1, CCNB1, SAC3D1, NCAPD2, BUB1, OIP5, NUSAP1, CIT
GO:0007049 cell cycle 22
RACGAP1, CCNE2, PKMYT1, RNF8, WEE1, KAT2B, CKS1B, SETD8, CLSPN, MAPK6, CCNF, CCNE1, CCNB1, SAC3D1,
NCAPD2, BUB1, OIP5, NUSAP1, JUB, CIT, PCNP, PSRC1
GO:0008283 cell proliferation 17
MPL, CKS1B, CREG1, CENPF, PRG4, LRP2, THPO, CBFA2T3, BUB1, BST2, ZFP36L2, ERF, BIN1, AMELX, SLC29A2,
NANOG, DAB2
Genes that are highlighted in bold are over-expressed, and the rest of the genes are under expressed.
doi: 10.1371/journal.pone.0084646.t005
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Figure 6.  Confirmation of DE genes using quantitative RT-PCR.  MCF-7 and MCF-7-Cd clonal cell lines (Cd-4, -6, -7, -8, and
-12) were plated in 10 cm plates and total RNA was isolated for gene expression analysis using quantitative RT-PCR. Data are
presented as relative fold changes with MCF-7 as the control and all fold changes are normalized to GAPDH (relative fold=2∆∆Ct gene/
∆∆CtGAPDH) with p<0.001.
doi: 10.1371/journal.pone.0084646.g006
Cadmium Alters Gene Expression in Breast Cancer
PLOS ONE | www.plosone.org 11 December 2013 | Volume 8 | Issue 12 | e84646
exposed to cadmium [75]. Contrary to our study, the genes
most significantly altered by chronic cadmium exposure did not
include many metallothionein genes. However, the authors did
identify LASP1 (LIM and SH3 protein 1) and ANXA2P2
(annexin A2 pseudogene 2) as being elevated and FAM182A
(family with sequence homology 182) as being down-regulated,
which is consistent with our results. We speculate that the
observed differences between Garrett’s study and ours are
likely associated with several variable factors including cell type
(kidney tubule cells versus breast cancer cells), cadmium
concentration (10-5 M versus 10-7 M), and length of cadmium
exposure (13 versus >180 days). Unfortunately, the authors
only reported a short list of genes with p<0.001, even though a
much larger set of genes with p<0.01 was apparently
generated, and it would be interesting to compare our results
with this larger data set.
It is important to note that our study has only identified genes
that were deregulated in all five clonal cadmium cells lines. As
a result, there may be genes deregulated in only a subset of
the cadmium clones that were not picked up in this study. Of
particular interest is SDF-1, a gene that we have previously
shown to be elevated in over 70% of the cadmium-adapted
clonal cell lines generated [20]. Consistent with this, our
Table 6. Summary of Gene Expression Fold Changes.





















































































White: Genes over-expressed in cadmium exposed cells; Gray: Genes down-
regulated in cadmium exposed cells.
doi: 10.1371/journal.pone.0084646.t006
microarray data also identified SDF-1 as one of the genes
elevated in four of the five MCF-7-Cd cell lines used in this
study (data not shown). Therefore, future analysis using less
stringent criteria may identify additional genes relevant to
cadmium-induced carcinogenesis.
This study is the first to identify gene expression patterns
that differentiate breast cancer cells exposed to cadmium for
prolonged periods of time versus those that have not. Our
results demonstrate that prolonged cadmium exposure directly
results in the deregulation of genes previously identified as
being associated with breast cancer. While some of the
deregulated genes were expected (cadmium/metal response
genes), many are newly identified as cadmium-associated
genes. Furthermore, these cadmium-associated genes are
involved in multiple biological processes (i.e. cell growth and
apoptosis) and molecular functions (i.e. cadmium/metal ion
binding and transcription factor activity). The most intriguing
finding from this study is that all five clonal cadmium cell lines
share a common gene expression signature, suggesting that
mammary tumors with high cadmium levels may share a
similar expression profile (Figures 1 and 2). Therefore, future
microarray analysis of mammary tumors with elevated
cadmium levels will provide insight into the potential role of the
bio-accumulated cadmium in breast cancer development and
progression. Our results demonstrate the cellular and
molecular impacts of cadmium on breast cancer
carcinogenesis and emphasize the importance of studying the
effects of chronic cadmium exposure on breast cancer.
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